Dr Bob Coleman
Dr Bob Coleman is a pharmacologist with a keen appreciation of the value of using human cells and tissues in the search for new medicines to treat human disease. He worked for 30 years for the Glaxo group of companies, where he gained a wide experience of the drug discovery/development process. In 1995, he left GlaxoWellcome, and joined a colleague in founding Pharmagene, now Asterand (www.asterand.com), the first drug discovery and development company to work exclusively on human biology. In November 2003 he was awarded an honorary DSc by DeMontfort University, Leicester, in recognition of his scientific achievements and his contributions to the experimental use of donated human tissues in drug research. Bob Coleman is now an independent consultant in drug discovery.
By Rebecca Ram I was pleased to be invited to give a presentation on the issues concerning use of animals in research at a recent workshop hosted by Advocates for Animals, the UK’s first legal organisation devoted to animal protection. The theme of the workshop was “Animal experiments; the law, the framework and the alternatives”. […]
Safer Medicines Trust at the 11th World Congress on Alternatives (WC11)Scientific consultant Rebecca Ram presented during a virtual session as part of the ‘YOU-WC11’ mentoring programme. The session theme was ‘Challenges and Opportunities for Expanding the 3Rs’’ and was particularly aimed at early career scientists. The session was further divided to discuss two topics; ‘Dropping an R: Is it Time to Retire Refinement?‘ featuring Charu Chandrasekera of […]
